.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Citi
Merck
Argus Health
Mallinckrodt
Colorcon
Baxter
Chinese Patent Office
UBS
AstraZeneca

Generated: December 15, 2017

DrugPatentWatch Database Preview

Patents Expiring in May 2026

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Mayne PharmaSORILUXcalcipotrieneAEROSOL, FOAM;TOPICAL022563-001Oct 6, 2010RXYesYes► Subscribe► Subscribe► SubscribeYUSE OF A CALCIPOTRIENE CONTAINING FOAM FOR THE TREATMENT OF PSORIASIS
Sunovion Pharms IncLATUDAlurasidone hydrochlorideTABLET;ORAL200603-002Oct 28, 2010RXYesNo► Subscribe► Subscribe► SubscribeYTREATMENT OF SCHIZOPHRENIA
Sunovion Pharms IncLATUDAlurasidone hydrochlorideTABLET;ORAL200603-004Apr 26, 2012RXYesNo► Subscribe► Subscribe► SubscribeYTREATMENT OF SCHIZOPHRENIA
Mayne PharmaSORILUXcalcipotrieneAEROSOL, FOAM;TOPICAL022563-001Oct 6, 2010RXYesYes► Subscribe► Subscribe► SubscribeYUSE OF CALCIPOTRIENE FOAM FOR THE TOPICAL TREATMENT OF PLAQUE PSORIASIS IN PATIENTS AGED 18 YEARS AND OLDER
Sunovion Pharms IncLATUDAlurasidone hydrochlorideTABLET;ORAL200603-003Dec 7, 2011RXYesNo► Subscribe► Subscribe► SubscribeYTREATMENT OF SCHIZOPHRENIA
TaroTOPICORTdesoximetasoneSPRAY;TOPICAL204141-001Apr 11, 2013ATRXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER
Sunovion Pharms IncLATUDAlurasidone hydrochlorideTABLET;ORAL200603-001Oct 28, 2010RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF SCHIZOPHRENIA
Sunovion Pharms IncLATUDAlurasidone hydrochlorideTABLET;ORAL200603-005Jul 12, 2013RXYesNo► Subscribe► Subscribe► SubscribeYTREATMENT OF SCHIZOPHRENIA
Forest Labs LlcNAMZARICdonepezil hydrochloride; memantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL206439-002Dec 23, 2014ABRXYesYes► Subscribe► Subscribe► SubscribeY
Forest Labs LlcNAMENDA XRmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL022525-004Jun 21, 2010ABRXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Medtronic
Fuji
UBS
Moodys
Farmers Insurance
Federal Trade Commission
Harvard Business School
Chubb
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot